Healthcare provider profile · identity verified

Matthew Peter Green, M.D.

Family Practice · LOUISA, VA · NPI 1144203308

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	534	159
Amlodipine Besylate	Amlodipine Besylate	436	124
Lisinopril	Lisinopril	426	115
Rosuvastatin Calcium	Rosuvastatin Calcium	408	122
Hydrochlorothiazide	Hydrochlorothiazide	324	100
Losartan Potassium	Losartan Potassium	281	89
Omeprazole	Omeprazole	263	76
Pravastatin Sodium	Pravastatin Sodium	249	78
Metoprolol Succinate	Metoprolol Succinate	240	65
Levothyroxine Sodium	Levothyroxine Sodium	232	67
Allopurinol	Allopurinol	196	61
Ezetimibe	Ezetimibe	186	56
Metformin Hcl Er	Metformin Hcl	178	63
Tamsulosin Hcl	Tamsulosin Hcl	175	53
Pantoprazole Sodium	Pantoprazole Sodium	163	56
Metformin Hcl	Metformin Hcl	160	51
Escitalopram Oxalate	Escitalopram Oxalate	148	49
Furosemide	Furosemide	144	52
Gabapentin	Gabapentin	139	42
Albuterol Sulfate Hfa	Albuterol Sulfate	118	44
Eliquis	Apixaban	107	30
Duloxetine Hcl	Duloxetine Hcl	106	30
Potassium Chloride	Potassium Chloride	99	37
Simvastatin	Simvastatin	99	32
Sertraline Hcl	Sertraline Hcl	94	30
Fluticasone Propionate	Fluticasone Propionate	93	30
Jardiance	Empagliflozin	86	30
Metoprolol Tartrate	Metoprolol Tartrate	86	25
Montelukast Sodium	Montelukast Sodium	82	27
Carvedilol	Carvedilol	81	25
Famotidine	Famotidine	80	28
Trazodone Hcl	Trazodone Hcl	76	32
Hydroxyzine Hcl	Hydroxyzine Hcl	74	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	20
Esomeprazole Magnesium	Esomeprazole Magnesium	63	19
Atenolol	Atenolol	60	17
Cephalexin	Cephalexin	58	55
Clonidine Hcl	Clonidine Hcl	56	12
Glimepiride	Glimepiride	54	16
Azithromycin	Azithromycin	53	48
Glipizide Er	Glipizide	52	17
Amitriptyline Hcl	Amitriptyline Hcl	51	14
Ozempic	Semaglutide	49	12
Mirtazapine	Mirtazapine	47	14
Amoxicillin	Amoxicillin	45	41
Zolpidem Tartrate	Zolpidem Tartrate	45	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	15
Januvia	Sitagliptin Phosphate	44	11
Fluoxetine Hcl	Fluoxetine Hcl	43	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	39
Cefdinir	Cefdinir	42	29
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	42	42
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Benazepril Hcl	Benazepril Hcl	41	suppressed
Prednisone	Prednisone	41	29
Spironolactone	Spironolactone	40	14
Diclofenac Sodium	Diclofenac Sodium	38	21
Fenofibrate	Fenofibrate Nanocrystallized	38	11
Clopidogrel	Clopidogrel Bisulfate	36	14
Lorazepam	Lorazepam	36	suppressed
Clonazepam	Clonazepam	33	suppressed
Meloxicam	Meloxicam	33	suppressed
Hydrocortisone	Hydrocortisone	31	21
Lidocaine	Lidocaine	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	12
Tizanidine Hcl	Tizanidine Hcl	31	12
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Finasteride	Finasteride	28	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Ketoconazole	Ketoconazole	26	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Verapamil Er	Verapamil Hcl	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Buspirone Hcl	Buspirone Hcl	23	suppressed
Jantoven	Warfarin Sodium	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Fluconazole	Fluconazole	22	16
Nifedipine Er	Nifedipine	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Nitroglycerin	Nitroglycerin	18	11
Nystatin	Nystatin	18	12
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Glipizide	Glipizide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Valsartan	Valsartan	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Naproxen	Naproxen	12	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	11
Mounjaro	Tirzepatide	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Ramipril	Ramipril	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error